English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1863]
News [4266]
Articles [399]
Editorials [10]
Conferences [107]
elearning [41]
Gene can predict the prognosis of patients with breast cancer and their response to treatment
Gene can predict the prognosis of patients with breast cancer and their response to treatment
Breast cancer replicates brain development process
Breast cancer replicates brain development process
Breast cancer drug costing tens of thousands of pounds more than other treatments 'unaffordable' for NHS
Breast cancer drug costing tens of thousands of pounds more than other treatments 'unaffordable' for NHS
'Dustman' protein helps bin cancer cells
'Dustman' protein helps bin cancer cells
EMA alerts EU healthcare professionals after vials of falsified Herceptin identified
EMA alerts EU healthcare professionals after vials of falsified Herceptin identified
Biomarker may predict recurrence of breast cancer and treatment response
Biomarker may predict recurrence of breast cancer and treatment response
AACR: Targeted investigational therapy shows early promise against multiple cancer types
AACR: Targeted investigational therapy shows early promise against multiple cancer types
AACR: Study identifies frequent cause of breast cancer resistance to investigational PI3K-alpha inhibitor
AACR: Study identifies frequent cause of breast cancer resistance to investigational PI3K-alpha inhibitor
AACR: Study identifies potential approach to overcome breast cancer resistance to HER2-targeted therapies
AACR: Study identifies potential approach to overcome breast cancer resistance to HER2-targeted therapies
AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratinib
AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratinib
<1...310311312313314...427>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top